David A. Neumann Anternational Life Sciences Anstitute St International Life Sciences Institute St
This work recognizes that an understanding of variability in response is critical in accounting for interindividual variability in susceptibility and, hence, risk, if the regulatory community and others are expected to characterize human health risks associated with exposure to chemicals. Models for incorporating measures of response variability in the risk assessment process are critically reviewed and illustrated with published data.
This work recognizes that an understanding of variability in response is critical in accounting for interindividual variability in susceptibility and,...
